Cargando…
Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
BACKGROUND: The identification of large‐artery stiffness as a major, independent risk factor for cardiovascular disease–associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/tra...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382090/ https://www.ncbi.nlm.nih.gov/pubmed/37421280 http://dx.doi.org/10.1161/JAHA.122.028421 |
_version_ | 1785080606745427968 |
---|---|
author | Akiyoshi, Kei Fujimori, Tomonari Fu, Xiuping Shah, Aparna P. Yamaguchi, Atsushi Steenbergen, Charles Santhanam, Lakshmi Berkowitz, Dan Tuday, Eric Baraban, Jay M. Das, Samarjit |
author_facet | Akiyoshi, Kei Fujimori, Tomonari Fu, Xiuping Shah, Aparna P. Yamaguchi, Atsushi Steenbergen, Charles Santhanam, Lakshmi Berkowitz, Dan Tuday, Eric Baraban, Jay M. Das, Samarjit |
author_sort | Akiyoshi, Kei |
collection | PubMed |
description | BACKGROUND: The identification of large‐artery stiffness as a major, independent risk factor for cardiovascular disease–associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/trax microRNA‐degrading enzyme confer protection against aortic stiffness induced by chronic ingestion of high‐salt water (4%NaCl in drinking water for 3 weeks) or associated with aging. Therefore, there is heightened interest in identifying interventions capable of inhibiting translin/trax RNase activity, as these may have therapeutic efficacy in large‐artery stiffness. METHODS AND RESULTS: Activation of neuronal adenosine A(2A) receptors (A(2A)Rs) triggers dissociation of trax from its C‐terminus. As A(2A)Rs are expressed by vascular smooth muscle cells (VSMCs), we investigated whether stimulation of A(2A)R on vascular smooth muscle cells promotes the association of translin with trax and, thereby increases translin/trax complex activity. We found that treatment of A7r5 cells with the A(2A)R agonist CGS21680 leads to increased association of trax with translin. Furthermore, this treatment decreases levels of pre‐microRNA‐181b, a target of translin/trax, and those of its downstream product, mature microRNA‐181b. To check whether A(2A)R activation might contribute to high‐salt water–induced aortic stiffening, we assessed the impact of daily treatment with the selective A(2A)R antagonist SCH58261 in this paradigm. We found that this treatment blocked aortic stiffening induced by high‐salt water. Further, we confirmed that the age‐associated decline in aortic pre‐microRNA‐181b/microRNA‐181b levels observed in mice also occurs in humans. CONCLUSIONS: These findings suggest that further studies are warranted to evaluate whether blockade of A(2A)Rs may have therapeutic potential in treating large‐artery stiffness. |
format | Online Article Text |
id | pubmed-10382090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103820902023-07-29 Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness Akiyoshi, Kei Fujimori, Tomonari Fu, Xiuping Shah, Aparna P. Yamaguchi, Atsushi Steenbergen, Charles Santhanam, Lakshmi Berkowitz, Dan Tuday, Eric Baraban, Jay M. Das, Samarjit J Am Heart Assoc Original Research BACKGROUND: The identification of large‐artery stiffness as a major, independent risk factor for cardiovascular disease–associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/trax microRNA‐degrading enzyme confer protection against aortic stiffness induced by chronic ingestion of high‐salt water (4%NaCl in drinking water for 3 weeks) or associated with aging. Therefore, there is heightened interest in identifying interventions capable of inhibiting translin/trax RNase activity, as these may have therapeutic efficacy in large‐artery stiffness. METHODS AND RESULTS: Activation of neuronal adenosine A(2A) receptors (A(2A)Rs) triggers dissociation of trax from its C‐terminus. As A(2A)Rs are expressed by vascular smooth muscle cells (VSMCs), we investigated whether stimulation of A(2A)R on vascular smooth muscle cells promotes the association of translin with trax and, thereby increases translin/trax complex activity. We found that treatment of A7r5 cells with the A(2A)R agonist CGS21680 leads to increased association of trax with translin. Furthermore, this treatment decreases levels of pre‐microRNA‐181b, a target of translin/trax, and those of its downstream product, mature microRNA‐181b. To check whether A(2A)R activation might contribute to high‐salt water–induced aortic stiffening, we assessed the impact of daily treatment with the selective A(2A)R antagonist SCH58261 in this paradigm. We found that this treatment blocked aortic stiffening induced by high‐salt water. Further, we confirmed that the age‐associated decline in aortic pre‐microRNA‐181b/microRNA‐181b levels observed in mice also occurs in humans. CONCLUSIONS: These findings suggest that further studies are warranted to evaluate whether blockade of A(2A)Rs may have therapeutic potential in treating large‐artery stiffness. John Wiley and Sons Inc. 2023-07-08 /pmc/articles/PMC10382090/ /pubmed/37421280 http://dx.doi.org/10.1161/JAHA.122.028421 Text en © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Akiyoshi, Kei Fujimori, Tomonari Fu, Xiuping Shah, Aparna P. Yamaguchi, Atsushi Steenbergen, Charles Santhanam, Lakshmi Berkowitz, Dan Tuday, Eric Baraban, Jay M. Das, Samarjit Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness |
title | Adenosine A(2A)
Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness |
title_full | Adenosine A(2A)
Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness |
title_fullStr | Adenosine A(2A)
Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness |
title_full_unstemmed | Adenosine A(2A)
Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness |
title_short | Adenosine A(2A)
Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness |
title_sort | adenosine a(2a)
receptor regulates microrna‐181b expression in aorta: therapeutic implications for large‐artery stiffness |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382090/ https://www.ncbi.nlm.nih.gov/pubmed/37421280 http://dx.doi.org/10.1161/JAHA.122.028421 |
work_keys_str_mv | AT akiyoshikei adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT fujimoritomonari adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT fuxiuping adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT shahaparnap adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT yamaguchiatsushi adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT steenbergencharles adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT santhanamlakshmi adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT berkowitzdan adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT tudayeric adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT barabanjaym adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness AT dassamarjit adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness |